Lanthanum Carbonate: A Review of its Use in Lowering Serum Phosphate in Patients with End-Stage Renal Disease

Author： Curran Monique P.   Robinson Dean M.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.69, Iss.16, 2009-11, pp. : 2329-2349

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sevelamer Hydrochloride: A Review of its Use for Hyperphosphataemia in Patients with End-Stage Renal Disease on Haemodialysis

By Goldsmith David R.   Scott Lesley J.   Cvetković Risto S.   Plosker Greg L.  

Drugs, Vol. 68, Iss. 1, 2008-01 ,pp. : 85-104

Adis International

Access to resources Recommend Favorite

Cinacalcet: A Pharmacoeconomic Review of its Use in Secondary Hyperparathyroidism in End-Stage Renal Disease

By Plosker Greg L.  

PharmacoEconomics, Vol. 29, Iss. 9, 2011-09 ,pp. : 807-821

Adis International

Access to resources Recommend Favorite

Lanthanum carbonate: a guide to its use as a phosphate-binding agent in patients with chronic kidney disease

By  

Drugs & Therapy Perspectives, Vol. 26, Iss. 8, 2010-08 ,pp. : 1-4

Adis International

Access to resources Recommend Favorite

Pharmacokinetics of Rosiglitazone in Patients with End-stage Renal Disease

By Thompson-Culkin K   Zussman B   Miller AK   Freed MI  

The Journal of International Medical Research, Vol. 30, Iss. 4, 2002-07 ,pp. : 391-399

Field House Publishing

Access to resources Recommend Favorite

Epidemiology of end-stage renal disease

By Roderick Paul  

Clinical Medicine, Vol. 2, Iss. 3, 2002-05 ,pp. : 200-204

Royal College Of Physicians

Access to resources Recommend Favorite